Bvf Inc Ac Immune Sa Call Options Transaction History
Bvf Inc
- $3.34 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACIU
# of Institutions
41Shares Held
29MCall Options Held
92.9KPut Options Held
46.3K-
Avidity Partners Management LP Dallas, TX4.47MShares$17.8 Million0.51% of portfolio
-
Black Rock Inc. New York, NY2.54MShares$10.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA2.01MShares$8.01 Million0.23% of portfolio
-
Morgan Stanley New York, NY1.38MShares$5.52 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.12MShares$4.47 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $333M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...